TCN1 and Alzheimer disease: Transcobalamin-1 was also the top-ranked biomarker for the progression comparison of MCI versus AD samples (AUC 0.83, Supplementary Figure S3), which showed decreased levels in AD saliva compared to MCI saliva in this study.